COVID-19 in der Intensivmedizin

The coronavirus disease 2019 (COVID-19) pandemic can lead to a severe course of disease in immunosuppressed patients requiring intensive care unit treatment even though a number of new vaccines and new antiviral drugs exist. One of the main reasons for this is the generally poorer immune response un...

Descripción completa

Detalles Bibliográficos
Autores principales: Floß, Niklas, Tebbe, Bastian, Rohn, Hana, Witzke, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2023
Materias:
Leitthema
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807091/
http://dx.doi.org/10.1007/s11560-022-00623-5
_version_ 1784862642798592000
author Floß, Niklas
Tebbe, Bastian
Rohn, Hana
Witzke, Oliver
author_facet Floß, Niklas
Tebbe, Bastian
Rohn, Hana
Witzke, Oliver
author_sort Floß, Niklas
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic can lead to a severe course of disease in immunosuppressed patients requiring intensive care unit treatment even though a number of new vaccines and new antiviral drugs exist. One of the main reasons for this is the generally poorer immune response under immunosuppression. Therefore, it is all the more important to know the stages of the disease and to select the currently available therapeutic options accordingly.
format Online
Article
Text
id pubmed-9807091
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-98070912023-01-04 COVID-19 in der Intensivmedizin Floß, Niklas Tebbe, Bastian Rohn, Hana Witzke, Oliver Nephrologie Leitthema The coronavirus disease 2019 (COVID-19) pandemic can lead to a severe course of disease in immunosuppressed patients requiring intensive care unit treatment even though a number of new vaccines and new antiviral drugs exist. One of the main reasons for this is the generally poorer immune response under immunosuppression. Therefore, it is all the more important to know the stages of the disease and to select the currently available therapeutic options accordingly. Springer Medizin 2023-01-02 2023 /pmc/articles/PMC9807091/ http://dx.doi.org/10.1007/s11560-022-00623-5 Text en © The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leitthema
Floß, Niklas
Tebbe, Bastian
Rohn, Hana
Witzke, Oliver
COVID-19 in der Intensivmedizin
title COVID-19 in der Intensivmedizin
title_full COVID-19 in der Intensivmedizin
title_fullStr COVID-19 in der Intensivmedizin
title_full_unstemmed COVID-19 in der Intensivmedizin
title_short COVID-19 in der Intensivmedizin
title_sort covid-19 in der intensivmedizin
topic Leitthema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807091/
http://dx.doi.org/10.1007/s11560-022-00623-5
work_keys_str_mv AT floßniklas covid19inderintensivmedizin
AT tebbebastian covid19inderintensivmedizin
AT rohnhana covid19inderintensivmedizin
AT witzkeoliver covid19inderintensivmedizin

Ejemplares similares